Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations — Stella

Home/Chronic Obstructive Pulmonary Disease/Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations

View on ClinicalTrials.gov

Recruiting

Back to Chronic Obstructive Pulmonary Disease trials

Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United Kingdom

Cambridge University Hospital NHS Trust, Addenbrookes Hospital, Cambridge

Key details

Phase

Post-approval study

Sponsor

Dr Ian B Wilkinson

Collaborators

University of Aberdeen, NHS Greater Glasgow and Clyde

Enrollment target

~1,311 participants

Started

March 2024

Primary completion

June 2028

Age range

40 Years and older

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.